ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,926Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 2456

$1.3M Total Retail Price of All Prescriptions

Rank: 20 out of 2456

770 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 770 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 770 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 20,362 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,105 1,068 1 9
FUROSEMIDE 1,049 937 2 8
SIMVASTATIN 778 660 3 2
OMEPRAZOLE 660 554 4 3
LEVOTHYROXINE SODIUM 579 454 5 4
LISINOPRIL 494 400 6 1
METOPROLOL TARTRATE 479 400 7 10
CARVEDILOL 405 367 8 54
HYDROCODONE-ACETAMINOPHEN 397 304 S3 9 20
CITALOPRAM HBR 395 367 10 14
LOVASTATIN 394 370 11 34
GLIMEPIRIDE 378 351 12 74
TRAZODONE HCL 377 315 13 17
HYDROCHLOROTHIAZIDE 375 331 14 7
ATORVASTATIN CALCIUM 361 321 15 12
SERTRALINE HCL 347 330 16 21
METFORMIN HCL 339 254 17 11
AMLODIPINE BESYLATE 311 263 18 5
POTASSIUM CHLORIDE 305 274 19 33
CRESTOR 292 228 20 25
LOSARTAN POTASSIUM 286 238 21 18
DONEPEZIL HCL 271 259 22 23
ALENDRONATE SODIUM 241 221 23 19
AMILORIDE-HYDROCHLOROTHIAZIDE 224 200 10 24 326
JANUVIA 195 177 25 81
TRAMADOL HCL 193 144 26 24
RANITIDINE HCL 192 186 27 31
ATENOLOL 190 177 28 6
DOXAZOSIN MESYLATE 175 149 29 71
PANTOPRAZOLE SODIUM 175 153 29 37
QUETIAPINE FUMARATE 169 153 31 47
POLYETHYLENE GLYCOL 3350 166 156 32 64
NITROGLYCERIN PATCH 162 162 33 134
OLANZAPINE 161 134 34 57
TAMSULOSIN HCL 161 128 34 32
DIVALPROEX SODIUM 157 132 36 51
ZETIA 154 123 37 86
PREDNISONE 154 147 37 39
PRAVASTATIN SODIUM 152 131 39 15
RISPERIDONE 152 126 39 50
MIRTAZAPINE 151 146 41 29
NYSTATIN 148 135 42 99
LISINOPRIL-HYDROCHLOROTHIAZIDE 148 128 42 41
GABAPENTIN 140 120 44 16
NAMENDA 137 137 45 42
SPIRONOLACTONE 133 114 46 73
PROAIR HFA 127 91 47 22
CLOTRIMAZOLE-BETAMETHASONE 121 118 48 182
NAPROXEN 121 77 48 109
ADVAIR DISKUS 117 76 50 36
BENZTROPINE MESYLATE 116 60 R 51 126
CLONIDINE HCL 116 96 51 111
PAROXETINE HCL 114 100 53 56
CYMBALTA 112 76 54 65
DIGOXIN 107 107 55 49
LIDODERM 104 90 56 58
LANTUS 102 98 57 44
ZOLPIDEM TARTRATE 100 77 58 28
IBUPROFEN 97 60 59 52
CLOZAPINE 96 74 60 75
NOVOLOG 96 94 60 100
CLOPIDOGREL 95 69 62 55
NIFEDIPINE ER 92 88 63 61
IPRATROPIUM-ALBUTEROL 86 80 64 85
OXYBUTYNIN CHLORIDE ER 85 57 65 94
HUMALOG 85 83 65 123
SULFAMETHOXAZOLE-TRIMETHOPRIM 82 75 67 147
CELEBREX 81 71 68 127
OXYCODONE-ACETAMINOPHEN 79 55 S2 69 35
METOPROLOL SUCCINATE 79 71 69 13
ISOSORBIDE MONONITRATE ER 77 66 71 48
GLYBURIDE 74 64 R 72 40
HYDROCORTISONE 74 55 72 234
LOSARTAN-HYDROCHLOROTHIAZIDE 73 66 74 117
NEXIUM 73 64 74 80
SINGULAIR 73 64 74 149
FENOFIBRATE 71 36 77 68
MECLIZINE HCL 70 63 78 107
PHENYTOIN SODIUM EXTENDED 70 55 78 140
THEOPHYLLINE ANHYDROUS 70 47 78 257
NYAMYC 69 68 81 316
DILTIAZEM HCL 69 69 81 207
TERAZOSIN HCL 69 63 81 76
FLUOXETINE HCL 68 31 84 45
METOLAZONE 68 59 84 271
CARBIDOPA-LEVODOPA 66 66 86 82
FLUDROCORTISONE ACETATE 64 39 87 260
LEVETIRACETAM 62 39 88 90
DILANTIN 62 52 88 212
DIOVAN 62 56 88 26
DILTIAZEM 24HR CD 62 62 88 113
BUDESONIDE 62 58 88 238
COMBIVENT 61 45 93 132
PRANDIN 61 54 93 293
OXYBUTYNIN CHLORIDE 61 61 93 152
HALOPERIDOL 60 15 96 137
SEROQUEL 60 58 96 102
NOVOLOG MIX 70-30 58 52 98 278
FINASTERIDE 58 58 98 66
PROPRANOLOL HCL 56 47 100 108
LEVOFLOXACIN 55 48 101 103
LIPITOR 53 48 102 63
NITROSTAT 52 43 103 169
ROPINIROLE HCL 52 47 103 148
ALLOPURINOL 52 37 103 27
MONTELUKAST SODIUM 52 44 103 216
AMILORIDE HCL 52 52 103 482
NIFEDICAL XL 52 39 103 184
SPIRIVA 51 35 109 43
AMOX TR-POTASSIUM CLAVULANATE 50 43 110 194
PLAVIX 50 35 110 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.